These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28464886)

  • 1. A lung cancer risk classifier comprising genome maintenance genes measured in normal bronchial epithelial cells.
    Yeo J; Crawford EL; Zhang X; Khuder S; Chen T; Levin A; Blomquist TM; Willey JC
    BMC Cancer; 2017 May; 17(1):301. PubMed ID: 28464886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repository.
    Crawford EL; Levin A; Safi F; Lu M; Baugh A; Zhang X; Yeo J; Khuder SA; Boulos AM; Nana-Sinkam P; Massion PP; Arenberg DA; Midthun D; Mazzone PJ; Nathan SD; Wainz R; Silvestri G; Tita J; Willey JC
    BMC Pulm Med; 2016 Jan; 16():16. PubMed ID: 26801409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technical advance in targeted NGS analysis enables identification of lung cancer risk-associated low frequency TP53, PIK3CA, and BRAF mutations in airway epithelial cells.
    Craig DJ; Morrison T; Khuder SA; Crawford EL; Wu L; Xu J; Blomquist TM; Willey JC
    BMC Cancer; 2019 Nov; 19(1):1081. PubMed ID: 31711466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAseq analysis of bronchial epithelial cells to identify COPD-associated genes and SNPs.
    Yeo J; Morales DA; Chen T; Crawford EL; Zhang X; Blomquist TM; Levin AM; Massion PP; Arenberg DA; Midthun DE; Mazzone PJ; Nathan SD; Wainz RJ; Nana-Sinkam P; Willey PFS; Arend TJ; Padda K; Qiu S; Federov A; Hernandez DR; Hammersley JR; Yoon Y; Safi F; Khuder SA; Willey JC
    BMC Pulm Med; 2018 Mar; 18(1):42. PubMed ID: 29506519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy.
    Whitney DH; Elashoff MR; Porta-Smith K; Gower AC; Vachani A; Ferguson JS; Silvestri GA; Brody JS; Lenburg ME; Spira A
    BMC Med Genomics; 2015 May; 8():18. PubMed ID: 25944280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CEBPG transcription factor correlates with antioxidant and DNA repair genes in normal bronchial epithelial cells but not in individuals with bronchogenic carcinoma.
    Mullins DN; Crawford EL; Khuder SA; Hernandez DA; Yoon Y; Willey JC
    BMC Cancer; 2005 Oct; 5():141. PubMed ID: 16255782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of antioxidant and DNA repair gene expression in normal airway epithelium associated with lung cancer diagnosis.
    Blomquist T; Crawford EL; Mullins D; Yoon Y; Hernandez DA; Khuder S; Ruppel PL; Peters E; Oldfield DJ; Austermiller B; Anders JC; Willey JC
    Cancer Res; 2009 Nov; 69(22):8629-35. PubMed ID: 19887610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shared Gene Expression Alterations in Nasal and Bronchial Epithelium for Lung Cancer Detection.
    AEGIS Study Team
    J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A volatile biomarker in breath predicts lung cancer and pulmonary nodules.
    Phillips M; Bauer TL; Pass HI
    J Breath Res; 2019 Jun; 13(3):036013. PubMed ID: 31085817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cis-acting genetic variation at an E2F1/YY1 response site and putative p53 site is associated with altered allele-specific expression of ERCC5 (XPG) transcript in normal human bronchial epithelium.
    Blomquist TM; Crawford EL; Willey JC
    Carcinogenesis; 2010 Jul; 31(7):1242-50. PubMed ID: 20233728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel serum based biomarker panel has complementary ability to preclude presence of early lung cancer for low dose CT (LDCT).
    Wang X; Zhi X; Yang Z; Tian H; Li Y; Li M; Zhao W; Zhang C; Wang T; Liu J; Shen D; Zheng C; Zhao D; Yang S; Qi J; Xin H; Stojadinovic A; Avital I; Lee LJ; Rao J; Zhang W
    Oncotarget; 2017 Jul; 8(28):45345-45355. PubMed ID: 28514755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.
    Sozzi G; Boeri M; Rossi M; Verri C; Suatoni P; Bravi F; Roz L; Conte D; Grassi M; Sverzellati N; Marchiano A; Negri E; La Vecchia C; Pastorino U
    J Clin Oncol; 2014 Mar; 32(8):768-73. PubMed ID: 24419137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal bronchial epithelial cell expression of glutathione transferase P1, glutathione transferase M3, and glutathione peroxidase is low in subjects with bronchogenic carcinoma.
    Crawford EL; Khuder SA; Durham SJ; Frampton M; Utell M; Thilly WG; Weaver DA; Ferencak WJ; Jennings CA; Hammersley JR; Olson DA; Willey JC
    Cancer Res; 2000 Mar; 60(6):1609-18. PubMed ID: 10749130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins.
    ; Guida F; Sun N; Bantis LE; Muller DC; Li P; Taguchi A; Dhillon D; Kundnani DL; Patel NJ; Yan Q; Byrnes G; Moons KGM; Tjønneland A; Panico S; Agnoli C; Vineis P; Palli D; Bueno-de-Mesquita B; Peeters PH; Agudo A; Huerta JM; Dorronsoro M; Barranco MR; Ardanaz E; Travis RC; Byrne KS; Boeing H; Steffen A; Kaaks R; Hüsing A; Trichopoulou A; Lagiou P; La Vecchia C; Severi G; Boutron-Ruault MC; Sandanger TM; Weiderpass E; Nøst TH; Tsilidis K; Riboli E; Grankvist K; Johansson M; Goodman GE; Feng Z; Brennan P; Johansson M; Hanash SM
    JAMA Oncol; 2018 Oct; 4(10):e182078. PubMed ID: 30003238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
    Silvestri GA; Vachani A; Whitney D; Elashoff M; Porta Smith K; Ferguson JS; Parsons E; Mitra N; Brody J; Lenburg ME; Spira A;
    N Engl J Med; 2015 Jul; 373(3):243-51. PubMed ID: 25981554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
    Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA
    J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
    Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
    J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
    Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
    BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity.
    Zang R; Wang X; Jin R; Lei Y; Huang J; Liu C; Zheng S; Zhou F; Wu Q; Sun N; Gao S; He J
    J Transl Med; 2019 Dec; 17(1):430. PubMed ID: 31888670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum mass profile signature as a biomarker of early lung cancer.
    Widlak P; Pietrowska M; Polanska J; Marczyk M; Ros-Mazurczyk M; Dziadziuszko R; Jassem J; Rzyman W
    Lung Cancer; 2016 Sep; 99():46-52. PubMed ID: 27565913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.